SIC
FRTX

Salem Investment Counselors’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Salem Investment Counselors’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 1036
2021
Q2 		$0 Buy
+1
New +$41 ﹤0.01% 968

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Salem Investment Counselors's FRTX Position: Q3 2021 in Review

Salem Investment Counselors sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2021, closing a stake of 1 share.

Salem Investment Counselors first reported a position in FRTX in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 27 funds tracked by Wall St. Rank hold FRTX as of Q3 2021.

  • Salem Investment Counselors reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Salem Investment Counselors sold 1 Fresh Tracks Therapeutics, Inc. Common Stock share in Q3 2021.
  • Salem Investment Counselors first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Salem Investment Counselors's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $0 in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Salem Investment Counselors's 13F filing for Q3 2021, filed 15 Nov 2021.